Bright Minds Biosciences Inc. (DRUG) KPIs and segments
DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
$20.76+0.25 (+1.22%)
Close on Nov 18, 2026Market cap $158.52MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Bright Minds Biosciences's business
Coming soon
This tab will track the numbers specific to Bright Minds Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?